Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design

Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design

Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation and destruction of the lung air–blood barrier, leading to irreversible and substantial respiratory function damage. Patients with coronavirus disease 2019 (COVID-19) have been encountered with a high risk of ARDS,...

Full description

Bibliographic Details
Main Authors: Qi Qiao, Xiong Liu, Ting Yang, Kexin Cui, Li Kong, Conglian Yang, Zhiping Zhang
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Acute respiratory distress syndrome
Nanomedicine
Anti-inflammatory therapy
Drug delivery
Targeting strategy
Acute lung injury
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383521001647

Internet

http://www.sciencedirect.com/science/article/pii/S2211383521001647

Similar Items